• Smoothened Signaling in Honeybee Olfaction

  2026-10-08

  Guo et al. characterize Smoothened (Smo) in Apis mellifera and connect its pharmacological modulation with olfactory receptor expression, electroantennographic responses, and odor-guided behavior. The study supports Smo as a candidate regulator of honeybee olfactory function, while its pharmacological and cross-species limits require careful interpretation.

• Carbapenemase Transmission in CREC: Guangdong Study

  2026-10-08

  Chen et al. integrated gene localization, antimicrobial susceptibility, transfer potential, mobile genetic elements, and strain relatedness to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. The findings identify plasmid-associated blaNDM-1 as a major resistance feature while showing why gene mobility and clonal surveillance should be interpreted together rather than as isolated measurements.

• Nifedipine and the Calcium–Liver Evidence Gap

  2026-10-07

  Nifedipine (BAY-a-1040) is examined here through a mechanistic lens that separates L-type calcium influx inhibition from PXR-driven hepatic adaptation. The article connects cardiac, iron-handling, and microbiological findings while defining what the current evidence does—and does not—support.

• NP-40 Lysis Buffer: Five Evidence Questions

  2026-10-07

  A source-grounded overview of non-denaturing lysis, lysate-based evidence, interpretation of FPR2/ALX research, sample-type scope, and the limitations that separate biochemical observations from therapeutic conclusions.

• Cyclosporin Variants and Mitochondrial Pore Inhibition

  2026-10-06

  Efimov and colleagues combined NMR spectroscopy, molecular dynamics, and a mitochondrial swelling assay to compare cyclosporins B–E with Cyclosporin A. Their results associate greater peptide-backbone flexibility with preserved mitochondrial permeability transition pore inhibition, while the more rigid Cyclosporin E lacked detectable activity in the reported assay range.

• P2Y2 Signaling in Microglial Aβ Clearance

  2026-10-06

  Kim et al. showed that Aβ1–42-treated microglia release extracellular nucleotides that activate P2Y2 receptors, increasing neighboring microglial migration, Aβ uptake, and peptide degradation. The study provides a mechanistic link between cellular stress, purinergic signaling, and microglial Aβ clearance, while remaining limited to primarily mouse-based in vitro evidence.

• Ionizing Radiation and Altered Neuronal Differentiation

  2026-10-05

  Eom et al. showed that ionizing radiation changes neuronal differentiation in C17.2 mouse neural stem-like cells, increasing neurite outgrowth and neuronal markers while producing an atypical neurotransmitter-receptor profile. The study links this phenotype to PI3K-STAT3-mGluR1 and PI3K-p53 signaling and extends the observation to mouse primary neural stem cells, while leaving important questions about in vivo relevance unresolved.

• Irinotecan in Cancer Research: Models and Evidence

  2026-10-05

  This overview examines Irinotecan (CPT-11) as a mechanistically defined topoisomerase I inhibitor in cancer research, with emphasis on model selection, tumor–stroma effects, published assembloid findings, and evidence limitations. It distinguishes supplier-reported cell and xenograft observations from the 2025 peer-reviewed gastric cancer assembloid study and avoids extending those findings beyond their demonstrated context.

• Pentoxifylline and Preterm Monocyte Hyperinflammation

  2026-10-04

  Schüller et al. examined how pentoxifylline modulates LPS-driven monocyte responses across preterm infants, term infants, and adults. The study links reduced inflammatory cytokine production to lower TLR4 expression and signaling, while also revealing age-dependent effects on monocyte phenotype, IL-10 production, and phagocytosis.

• MHY1485 and the mTORC1 Translational Question

  2026-10-03

  A source-grounded perspective on MHY1485 as an mTOR activator and autophagy-modulating research tool, using the LMP2A–mTORC1–GCNT3 axis in nasopharyngeal carcinoma to define opportunities, evidence boundaries, and translational questions.

• SGI-1027: Mechanism-First Epigenetic Assays

  2026-10-02

  SGI-1027 is a DNA methyltransferase inhibitor with a distinctive dual profile: direct DNMT inhibition and DNMT1 degradation. This article explains how to translate that chemistry into assays that distinguish DNA methylation inhibition from lysosomal, apoptotic, and pyroptotic phenotypes.

• Capsaicin-Activated Autophagy in Oxidative-Stressed BMSCs

  2026-10-01

  This study shows that capsaicin preserves rat bone marrow stromal cell function during hydrogen peroxide-induced oxidative stress while supporting antioxidant capacity and osteogenic differentiation. Its proposed mechanism connects TRPV1-associated calcium influx with autophagy and altered PI3K/AKT/mTOR signaling, providing a testable framework for osteoporosis-related cell protection.

• p-Cresyl Sulfate in CKD Cardiovascular Models

  2026-10-01

  p-Cresyl sulfate, also called p-tolyl hydrogen sulfate, is a protein-bound uremic retention solute used to model renal–cardiovascular mechanisms. Evidence links it to endothelial repair impairment and increased valvular interstitial cell calcification through klotho, SIRT1, HIF-1α, NF-κB, and RUNX2 signaling.

• Smoothened Signaling and Olfaction in Honeybees

  2026-09-30

  Guo et al. characterize Smoothened (Smo) in Apis mellifera and connect antenna-enriched Hedgehog signaling with olfactory receptor expression, electrophysiological responses, and odor-guided behavior. The study provides a useful insect-model framework for testing Smo-dependent sensory regulation while emphasizing that pharmacological dose and tissue context must be considered before translation to mammalian systems.

• Diphenyleneiodonium Chloride in Nrf2 Assays

  2026-09-30

  Diphenyleneiodonium chloride (DPI) is a dual-purpose research probe for separating redox enzyme activity from cAMP signaling modulation. This workflow-driven guide shows how to build time-resolved Nrf2, oxidative stress, NOX, and GPR3 assays while controlling for solubility, pathway cross-talk, and cytotoxicity.

7920 records 1/528 page Next 12345 下5页 Last page